Finance

āϞāĻŋāĻ¸ā§āϟ
WXXWY:OTCMKTS
Wuxi Biologics Cayman ADR
⧧⧍.ā§Ģā§Ŧ US$
+ā§Ļ.ā§Ēā§Ž%
(+ā§Ļ.ā§Ļā§Ŧā§Ļ) ā§§ āĻĻāĻŋ
ā§§ā§Ŧ āĻ…āĻ•ā§āĻŸā§‹, ā§Ē:ā§Ļā§Ļ:ā§Ļā§Ļ PM GMT -ā§Ē  ·   USD
āϏāĻŦ āϏāĻŋāĻŽā§āĻŦāϞ
āϏāĻŋāĻŽā§āĻŦāϞāĻĻāĻžāĻŽāĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ āĻ•āϰ⧁āύ% āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ
WXXWY-āĻāϰ āϜāĻ¨ā§āϝ āϏ⧇āϰāĻž āχāύāϏāĻžāχāϟ āĻœā§‡āύāĻžāϰ⧇āϟ āĻ•āϰāĻž āĻšāĻšā§āϛ⧇...
āϖ⧁āϞ⧁āύ
⧧⧍.ā§¨ā§¯Â US$
āϏāĻ°ā§āĻŦāĻžāϧāĻŋāĻ•
⧧⧍.ā§Ģā§Ŧ US$
āϏāĻ°ā§āĻŦāύāĻŋāĻŽā§āύ
⧧⧍.⧍ā§Ļ US$
āĻŽāĻžāĻ°ā§āϕ⧇āϟ āĻ•ā§āϝāĻžāĻĒ
ā§§.ā§¯ā§Žāϕ⧋
āĻ…ā§āϝāĻžāĻ­āĻžāϰ⧇āϜ āĻ­āϞāĻŋāωāĻŽ
ā§Ŧā§§.ā§Žā§¯Â āĻšāĻž
āĻ­āϞāĻŋāωāĻŽ
ā§§.ā§§ā§§Â āϞāĻž
ā§Ģ⧍ āϏāĻĒā§āϤāĻžāĻšā§‡āϰ āϏāĻ°ā§āĻŦā§‹āĻšā§āϚ āĻĻāĻžāĻŽ
ā§§ā§Ē.ā§Žā§Ļ US$
ā§Ģ⧍ āϏāĻĒā§āϤāĻžāĻšā§‡āϰ āϏāĻ°ā§āĻŦāύāĻŋāĻŽā§āύ āĻĻāĻžāĻŽ
ā§­.ā§Šā§Ļ US$
āĻŦāĻŋāϟāĻž
ā§Ļ.ā§Ļā§§
āφāωāϟāĻ¸ā§āĻŸā§āϝāĻžāĻ¨ā§āĻĄāĻŋāĻ‚ āĻļā§‡ā§ŸāĻžāϰ
⧍ā§Ļā§Ģ.ā§Žā§Ē āϕ⧋
āĻ•āĻ°ā§āĻŽā§€āϏāĻ‚āĻ–ā§āϝāĻž
ā§§ā§Ģ āĻšāĻž
āϖ⧁āϞ⧁āύ
⧧⧍.ā§¨ā§¯Â US$
āϏāĻ°ā§āĻŦāĻžāϧāĻŋāĻ•
⧧⧍.ā§Ģā§Ŧ US$
āϏāĻ°ā§āĻŦāύāĻŋāĻŽā§āύ
⧧⧍.⧍ā§Ļ US$
āĻŽāĻžāĻ°ā§āϕ⧇āϟ āĻ•ā§āϝāĻžāĻĒ
ā§§.ā§¯ā§Žāϕ⧋
āĻ…ā§āϝāĻžāĻ­āĻžāϰ⧇āϜ āĻ­āϞāĻŋāωāĻŽ
ā§Ŧā§§.ā§Žā§¯Â āĻšāĻž
āĻ­āϞāĻŋāωāĻŽ
ā§§.ā§§ā§§Â āϞāĻž
ā§Ģ⧍ āϏāĻĒā§āϤāĻžāĻšā§‡āϰ āϏāĻ°ā§āĻŦā§‹āĻšā§āϚ āĻĻāĻžāĻŽ
ā§§ā§Ē.ā§Žā§Ļ US$
ā§Ģ⧍ āϏāĻĒā§āϤāĻžāĻšā§‡āϰ āϏāĻ°ā§āĻŦāύāĻŋāĻŽā§āύ āĻĻāĻžāĻŽ
ā§­.ā§Šā§Ļ US$
āĻŦāĻŋāϟāĻž
ā§Ļ.ā§Ļā§§
āφāωāϟāĻ¸ā§āĻŸā§āϝāĻžāĻ¨ā§āĻĄāĻŋāĻ‚ āĻļā§‡ā§ŸāĻžāϰ
⧍ā§Ļā§Ģ.ā§Žā§Ē āϕ⧋
āĻ•āĻ°ā§āĻŽā§€āϏāĻ‚āĻ–ā§āϝāĻž
ā§§ā§Ģ āĻšāĻž
āĻ–āĻŦāϰ⧇āϰ āĻ¸ā§āĻŸā§‹āϰāĻŋ
āĻ“ā§Ÿā§‡āĻŦ āϏ⧋āĻ°ā§āϏ āĻ“ āĻ–āĻŦāϰ⧇āϰ āĻĒāĻžāĻ°ā§āϟāύāĻžāϰāĻĻ⧇āϰ āĻĨ⧇āϕ⧇
Simply Wall Street
Simply Wall Street
·
ā§§ā§Ž āĻŽāĻŋāύāĻŋāϟ āφāϗ⧇
InterDigital (IDCC) Stock Looks Reasonably Priced On Royalty Earnings
Seeking Alpha
Seeking Alpha
·
ā§Ēā§Š āĻŽāĻŋāύāĻŋāϟ āφāϗ⧇
S&P 500 Earnings Yield Jumps Over 5%; Sold The EMXC
Bloomberg.com
Bloomberg.com
·
ā§­ āϘāĻŖā§āϟāĻž āφāϗ⧇
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
āĻĒā§āϰ⧋āĻĢāĻžāχāϞ
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development. WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017. As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore. In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong. In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Wuxi Biologics Cayman ADR āϏāĻŽā§āĻĒāĻ°ā§āϕ⧇
āϏāĻŋāχāĻ“āĻāĻŋāĻļ⧇āĻ‚ āĻšā§‡āύ
āĻ•āĻ°ā§āĻŽā§€ā§§ā§Ē.ā§­Â āĻšāĻž
āĻĒā§āϰāϤāĻŋāĻˇā§āĻ āĻžāϰ āϤāĻžāϰāĻŋāϖ⧍ā§Ļā§§ā§Ļ
āĻšā§‡āĻĄāĻ•ā§‹ā§ŸāĻžāĻ°ā§āϟāĻžāϰ-
āϏ⧇āĻ•ā§āϟāϰ-
āĻ“ā§Ÿā§‡āĻŦāϏāĻžāχāϟwuxibiologics.com
āφāϗ⧇āϰ āϰāĻŋāĻĒā§‹āĻ°ā§āϟCNY-āĻ āϏāĻŦ āĻ­ā§āϝāĻžāϞ⧁
Loading Previous Earnings...
āωāĻĒāĻžāĻ°ā§āϜāύ
āĻŽā§‹āϟ āχāύāĻ•āĻžāĻŽ
CNY-āĻ āϏāĻŦ āĻ­ā§āϝāĻžāϞ⧁
āϏ⧇āĻĒ ā§¨ā§Ļ⧍ā§Ģ
āĻĄāĻŋāϏ⧇ ⧍ā§Ļ⧍ā§Ģ
āĻŽāĻžāĻ°ā§āϚ ⧍ā§Ļ⧍ā§Ŧ
āϜ⧁āύ ⧍ā§Ļ⧍ā§Ŧ
āωāĻĒāĻžāĻ°ā§āϜāύ
ā§Ģ⧝⧧.ā§Žā§Ē āϕ⧋
ā§Ģ⧝⧧.ā§Žā§Ē āϕ⧋
ā§Ģā§Žā§¯.ā§Šā§Ŧ āϕ⧋
ā§Ģā§Žā§¯.ā§Šā§Ŧ āϕ⧋
āĻĒā§āϰ⧋āĻĄāĻžāĻ•ā§āϟ āĻŦāĻŋāĻ•ā§āϰāĻŋ āĻ•āϰāĻžāϰ āĻ–āϰāϚ
ā§Šā§Ļā§Š.ā§Ģā§Ŧ āϕ⧋
ā§Šā§Ļā§Š.ā§Ģā§Ŧ āϕ⧋
ā§Šā§§ā§Ŧ.⧝ā§Ģ āϕ⧋
ā§Šā§§ā§Ŧ.⧝ā§Ģ āϕ⧋
āωāĻĒāĻžāĻ°ā§āϜāύ⧇āϰ āϜāĻ¨ā§āϝ āĻ–āϰāϚ
ā§Šā§Ļā§Š.ā§Ģā§Ŧ āϕ⧋
ā§Šā§Ļā§Š.ā§Ģā§Ŧ āϕ⧋
ā§Šā§§ā§Ŧ.⧝ā§Ģ āϕ⧋
ā§Šā§§ā§Ŧ.⧝ā§Ģ āϕ⧋
āϰāĻŋāϏāĻžāĻ°ā§āϚ āĻ“ āĻĄā§‡āϭ⧇āϞāĻĒāĻŽā§‡āĻ¨ā§āϟ āϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻ–āϰāϚ
⧍ā§Ģ.ā§Ēā§¯Â āϕ⧋
⧍ā§Ģ.ā§Ēā§¯Â āϕ⧋
⧍⧧.ā§Ģā§§Â āϕ⧋
⧍⧧.ā§Ģā§§Â āϕ⧋
āϰāĻŋāϏāĻžāĻ°ā§āϚ āĻ“ āĻĄā§‡āϭ⧇āϞāĻĒāĻŽā§‡āĻ¨ā§āϟ āϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻŽā§‹āϟ āĻ–āϰāϚ
-
-
-
-
āĻŦāĻŋāĻ•ā§āϰāĻŋ, āϏāĻžāϧāĻžāϰāĻŖ āĻ“ āĻ…ā§āϝāĻžāĻĄāĻŽāĻŋāύ āϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻ–āϰāϚ
ā§Ŧā§Š.ā§§ā§Ļ āϕ⧋
ā§Ŧā§Š.ā§§ā§Ļ āϕ⧋
ā§Ģ⧝.ā§§ā§Ŧ āϕ⧋
ā§Ģ⧝.ā§§ā§Ŧ āϕ⧋
āĻ…āĻĒāĻžāϰ⧇āϟāĻŋāĻ‚ āĻ–āϰāϚ
⧝⧍.ā§§ā§­Â āϕ⧋
⧝⧍.ā§§ā§­Â āϕ⧋
ā§Žā§Ŧ.ā§Ļā§§Â āϕ⧋
ā§Žā§Ŧ.ā§Ļā§§Â āϕ⧋
āĻ…āĻĒāĻžāϰ⧇āϟāĻŋāĻ‚ āϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻŽā§‹āϟ āĻ–āϰāϚ
ā§Šā§¯ā§Ģ.ā§­ā§ŠÂ āϕ⧋
ā§Šā§¯ā§Ģ.ā§­ā§ŠÂ āϕ⧋
ā§Ēā§Ļ⧍.⧝ā§Ŧ āϕ⧋
ā§Ēā§Ļ⧍.⧝ā§Ŧ āϕ⧋
āĻ…āĻĒāĻžāϰ⧇āϟāĻŋāĻ‚ āχāύāĻ•āĻžāĻŽ
⧧⧝ā§Ŧ.ā§§ā§§Â āϕ⧋
⧧⧝ā§Ŧ.ā§§ā§§Â āϕ⧋
ā§§ā§Žā§Ŧ.ā§Ēā§§Â āϕ⧋
ā§§ā§Žā§Ŧ.ā§Ēā§§Â āϕ⧋
āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āύāύ-āĻ…āĻĒāĻžāϰ⧇āϟāĻŋāĻ‚ āχāύāĻ•āĻžāĻŽ
ā§Š.ā§Šā§Ŧ āϕ⧋
ā§Š.ā§Šā§Ŧ āϕ⧋
ā§Ē.ā§¨ā§¨Â āϕ⧋
ā§Ē.ā§¨ā§¨Â āϕ⧋
āĻ…āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āφāχāĻŸā§‡āĻŽ-āϏāĻš EBT
⧧⧝ā§Ŧ.ā§Ēā§Ē āϕ⧋
⧧⧝ā§Ŧ.ā§Ēā§Ē āϕ⧋
ā§§ā§­ā§Ļ.⧝ā§Ŧ āϕ⧋
ā§§ā§­ā§Ļ.⧝ā§Ŧ āϕ⧋
āĻ…āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āφāχāĻŸā§‡āĻŽ āĻŦāĻžāĻĻ āĻĻāĻŋā§Ÿā§‡ EBT
ā§§ā§¯ā§Š.ā§Žā§¨Â āϕ⧋
ā§§ā§¯ā§Š.ā§Žā§¨Â āϕ⧋
ā§§ā§Ŧ⧝.ā§­ā§Ē āϕ⧋
ā§§ā§Ŧ⧝.ā§­ā§Ē āϕ⧋
āχāύāĻ•āĻžāĻŽ āĻŸā§āϝāĻžāĻ•ā§āϏ āϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻ–āϰāϚ
ā§Ēā§­.ā§Ŧā§§Â āϕ⧋
ā§Ēā§­.ā§Ŧā§§Â āϕ⧋
⧍ā§Ģ.ā§§ā§Ģ āϕ⧋
⧍ā§Ģ.ā§§ā§Ģ āϕ⧋
āĻĒā§āϰāϝ⧋āĻœā§āϝ āĻŸā§āϝāĻžāĻ•ā§āϏ āϰ⧇āϟ
⧍ā§Ē.⧍ā§Ē%
⧍ā§Ē.⧍ā§Ē%
ā§§ā§Ē.ā§­ā§§%
ā§§ā§Ē.ā§­ā§§%
āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āĻ…āĻĒāĻžāϰ⧇āϟāĻŋāĻ‚ āϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻ–āϰāϚ
-
-
-
-
āĻŽā§‹āϟ āχāύāĻ•āĻžāĻŽ
ā§§ā§¨ā§Ž.ā§Ēā§Ģ āϕ⧋
ā§§ā§¨ā§Ž.ā§Ēā§Ģ āϕ⧋
⧧⧍⧧.ā§¯ā§¯Â āϕ⧋
⧧⧍⧧.ā§¯ā§¯Â āϕ⧋
āĻŽā§‹āϟ āϞāĻžāϭ⧇āϰ āĻŽāĻžāĻ°ā§āϜāĻŋāύ
⧍⧧.ā§­ā§Ļ%
⧍⧧.ā§­ā§Ļ%
⧍ā§Ļ.ā§­ā§Ļ%
⧍ā§Ļ.ā§­ā§Ļ%
āφāĻ°ā§āύāĻŋāĻ‚ āĻĒāĻžāϰ āĻļā§‡ā§ŸāĻžāϰ
-
-
-
-
āχāĻ¨ā§āϟāĻžāϰ⧇āĻ¸ā§āϟ āĻ“ āχāύāϭ⧇āĻ¸ā§āϟāĻŽā§‡āĻ¨ā§āϟ āχāύāĻ•āĻžāĻŽ
ā§§ā§§.ā§Ģā§ŠÂ āϕ⧋
ā§§ā§§.ā§Ģā§ŠÂ āϕ⧋
ā§§ā§Ļ.ā§Ŧā§Ē āϕ⧋
ā§§ā§Ļ.ā§Ŧā§Ē āϕ⧋
āχāĻ¨ā§āϟāĻžāϰ⧇āĻ¸ā§āϟ āϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻ–āϰāϚ
-⧍.ā§¯ā§ŽÂ āϕ⧋
-⧍.ā§¯ā§ŽÂ āϕ⧋
-⧍.ā§¨ā§ŠÂ āϕ⧋
-⧍.ā§¨ā§ŠÂ āϕ⧋
āχāĻ¨ā§āϟāĻžāϰ⧇āĻ¸ā§āϟ āϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻŽā§‹āϟ āĻ–āϰāϚ
ā§Ž.ā§Ģā§Ģ āϕ⧋
ā§Ž.ā§Ģā§Ģ āϕ⧋
ā§Ž.ā§Ēā§§Â āϕ⧋
ā§Ž.ā§Ēā§§Â āϕ⧋
āĻĄā§‡āĻĒā§āϰāĻŋāϏāĻŋā§Ÿā§‡āĻļāύ āĻ“ āĻ…ā§āϝāĻžāĻŽāĻ°ā§āϟāĻžāχāĻœā§‡āĻļāύ āϚāĻžāĻ°ā§āϜ
-
-
-
-
EBITDA
ā§¨ā§¨ā§Š.ā§­ā§ŽÂ āϕ⧋
ā§¨ā§¨ā§Š.ā§­ā§ŽÂ āϕ⧋
⧍⧍⧭.ā§Šā§§Â āϕ⧋
⧍⧍⧭.ā§Šā§§Â āϕ⧋
āĻ…ā§āϝāĻžāϏ⧇āϟ āĻŦāĻŋāĻ•ā§āϰāĻŋ āĻ•āϰ⧇ āϞāĻžāĻ­ āĻŦāĻž āĻ•ā§āώāϤāĻŋ
ā§Šā§§.ā§­ā§ŠÂ āϕ⧋
ā§Šā§§.ā§­ā§ŠÂ āϕ⧋
-
-
AI āĻ•āĻ¨ā§āĻŸā§‡āĻ¨ā§āĻŸā§‡ āϭ⧁āϞ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āφāϰāĻ“ āϜāĻžāύ⧁āύ
Google āĻ…ā§āϝāĻžāĻĒā§āϞāĻŋāϕ⧇āĻļāĻžāύāϗ⧁āϞāĻŋ